Compare UBS & ISRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UBS | ISRG |
|---|---|---|
| Founded | 1862 | 1995 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 148.3B | 166.8B |
| IPO Year | 2014 | 1998 |
| Metric | UBS | ISRG |
|---|---|---|
| Price | $44.91 | $420.48 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 19 |
| Target Price | $60.30 | ★ $591.32 |
| AVG Volume (30 Days) | ★ 2.3M | 2.0M |
| Earning Date | 04-29-2026 | 04-21-2026 |
| Dividend Yield | ★ 1.29% | N/A |
| EPS Growth | N/A | ★ 22.59 |
| EPS | N/A | ★ 2.28 |
| Revenue | N/A | ★ $10,064,700,000.00 |
| Revenue This Year | $7.40 | $16.64 |
| Revenue Next Year | $2.83 | $13.91 |
| P/E Ratio | ★ $17.22 | $196.89 |
| Revenue Growth | N/A | ★ 20.51 |
| 52 Week Low | $30.39 | $427.84 |
| 52 Week High | $49.36 | $603.88 |
| Indicator | UBS | ISRG |
|---|---|---|
| Relative Strength Index (RSI) | 63.39 | 29.87 |
| Support Level | $40.93 | N/A |
| Resistance Level | $48.90 | $455.45 |
| Average True Range (ATR) | 0.76 | 14.06 |
| MACD | 0.15 | -3.02 |
| Stochastic Oscillator | 86.74 | 0.49 |
UBS is a global financial institution built around its core strength in wealth management, serving high and ultra-high-net-worth individuals. In Switzerland, it also operates as a traditional retail and commercial bank. Its investment bank and asset management divisions complement the wealth business, providing tailored solutions to UBS clients while serving third-party customers by leveraging UBS' global reach and expertise.
Intuitive develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 10,000 da Vinci systems in hospitals worldwide, with more than 6,000 installations in the US and a growing number in emerging markets.